Point72 Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.9M | Sell |
1,392,517
-94,427
| -6% | -$1.76M | 0.05% | 359 |
|
2025
Q1 | $27M | Buy |
1,486,944
+1,293,344
| +668% | +$23.5M | 0.06% | 320 |
|
2024
Q4 | $4.22M | Sell |
193,600
-244,100
| -56% | -$5.32M | 0.01% | 700 |
|
2024
Q3 | $12M | Buy |
437,700
+263,500
| +151% | +$7.21M | 0.03% | 466 |
|
2024
Q2 | $4.51M | Sell |
174,200
-177,900
| -51% | -$4.6M | 0.01% | 644 |
|
2024
Q1 | $10.6M | Buy |
+352,100
| New | +$10.6M | 0.03% | 578 |
|
2018
Q3 | – | Sell |
-506
| Closed | -$109K | – | 888 |
|
2018
Q2 | $109K | Buy |
+506
| New | +$109K | ﹤0.01% | 768 |
|